Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
BMJ Open|August 21, 2019
Study protocol for 'The Project About Loneliness and Social networks (PALS)': a pragmatic, randomised trial comparing a facilitated social network intervention (Genie) with a wait-list control for lonely and socially isolated peopleRebecca Band, Sean Ewings, Tara Cheetham-Blake, et al.The Journal of Antimicrobial Chemotherapy|December 22, 2016
Electronic prescribing system design priorities for antimicrobial stewardship: a cross-sectional survey of 142 UK infection specialistsKieran S Hand, Debbie Cumming, Susan Hopkins, et al.Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.The Lancet. Respiratory Medicine|October 11, 2020
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled studyNathan J Brendish, Stephen Poole, Vasanth V Naidu, et al.Trials|November 1, 2025
Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trialAndrew Cook, Jonathan Bamber, Fay Chinnery, et al.BMJ Open|November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centresDean Fennell, Daniel Griffiths, Zina Eminton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.Cancers|February 13, 2025
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical OncologySean Ewings, Nadia Peppa, Daniel Griffiths, et al.The Lancet. Oncology|October 17, 2021
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trialDean A Fennell, Sean Ewings, Christian Ottensmeier, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 9, 2015
A web-based intervention (RESTORE) to support self-management of cancer-related fatigue following primary cancer treatment: a multi-centre proof of concept randomised controlled trialClaire Foster, Chloe Grimmett, Christine M May, et al.Pageof 5